Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells

Eur J Cancer. 2013 May;49(8):2066-7. doi: 10.1016/j.ejca.2013.01.026. Epub 2013 Feb 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Arachidonic Acids / pharmacology*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Cannabinoid Receptor Agonists / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Endocannabinoids / pharmacology*
  • Epithelial-Mesenchymal Transition / drug effects
  • Female
  • Humans
  • Polyunsaturated Alkamides / pharmacology*
  • Wnt Signaling Pathway / drug effects*
  • beta Catenin / metabolism

Substances

  • Arachidonic Acids
  • Cannabinoid Receptor Agonists
  • Endocannabinoids
  • Polyunsaturated Alkamides
  • beta Catenin
  • anandamide